Walgreens and MyMedicalRecords Reach Settlement Agreement
LOS ANGELES, CA and DEERFIELD, IL--(Marketwired - Mar 6, 2014) -
MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary
MyMedicalRecords, Inc. (collectively, "MMR"), and Walgreen Co.
(NYSE: WAG) (NASDAQ: WAG) ("Walgreens") announced today that they
have entered into a Settlement and Licensing Agreement (the
"Agreement") to resolve two patent infringement lawsuits brought by
MMR. Pursuant to the terms of the Agreement, Walgreens purchased a
Non-Exclusive License to the MMR family of patents. The
settlement arises from litigation involving MMR's U.S. Patent No.
8,301,466 and U.S. Patent No. 8,498,883. MMR's patent portfolio
also includes U.S. Patent Nos. 8,121,855; 8,117,045; 8,117,646;
8,301,466; 8,321,240; 8,352,287; 8,352,288; 8,498,883; 8,626,532
and 8,645,161 as well as numerous pending
applications. Pursuant to the terms of the Agreement,
Walgreens has also agreed to sell MMR's MyMedicalRecords Personal
Health Record (the "MMR-PHR") on drugstore.com. The remaining
terms of the Agreement are confidential.
About MMRGlobal MMRGlobal, Inc., through its wholly-owned
subsidiary, MyMedicalRecords, Inc., (MMR) is a leading provider of
secure and easy-to-use online Personal Health Records ("PHRs") and
electronic safe deposit box storage solutions incorporating its
patented MyMedicalRecords PHR. Each MyMedicalRecords account
covers up to 10 family members, including pets, and enables users
to safely store medical records and images and other important
documents, such as copies of birth certificates, passports,
insurance policies, financial information, wills and advance
directives, in the system and access and share them anytime from
anywhere over an Internet-connected device anywhere in the
world. MyMedicalRecords is currently available in English and
Spanish, with other languages being added. Each MMR account
includes file upload, e-mail, inbound/outbound fax and voice
messaging as well as a special Emergency Login, which makes
potentially life-saving health information accessible to medical
personnel and first responders. Critical data is pre-selected by
users to protect the confidentiality of records in the account.
Additionally, each account includes numerous health management
tools such as automatic prescription alerts and appointment
reminders as well as a drug interaction tool that checks for
adverse reactions between over 30,000 prescriptions and
over-the-counter medications. The Company's professional offering,
MMRPro, is designed to give physicians' offices an easy and
cost-effective solution to digitize paper-based medical records and
share them with patients through an integrated patient portal. The
Company also owns a portfolio of biotech assets that include
anti-CD20 antibodies, data and samples from the FavId™ vaccine
clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma.
To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View
demos and video tutorials of the Company's products and services at
www.mmrtheater.com.
About Walgreens As the nation's largest drugstore chain with
fiscal 2013 sales of $72 billion, Walgreens (www.walgreens.com)
vision is to be the first choice in health and daily living for
everyone in America, and beyond. Each day, Walgreens provides more
than 6 million customers the most convenient, multichannel access
to consumer goods and services and trusted, cost-effective
pharmacy, health and wellness services and advice in communities
across America. Walgreens scope of pharmacy services includes
retail, specialty, infusion, medical facility and mail service,
along with respiratory services. These services improve health
outcomes and lower costs for payers including employers, managed
care organizations, health systems, pharmacy benefit managers and
the public sector. The company operates 8,206 drugstores in all 50
states, the District of Columbia, Puerto Rico and the U.S. Virgin
Islands. Take Care Health Systems is a Walgreens subsidiary that is
the largest and most comprehensive manager of worksite health and
wellness centers and in-store convenient care clinics, with more
than 750 locations throughout the country.
Forward-Looking Statements All statements in this press
release that are not strictly historical in nature, including,
without limitation, intellectual property enforcement actions,
infringement claims or litigation, intellectual property licenses,
and future performance, management's expectations, beliefs,
intentions, estimates or projections, constitute "forward-looking
statements." Such forward-looking statements involve known and
unknown risks, uncertainties and other factors that may cause MMR's
actual results to be materially different from historical results
or from any results expressed or implied by such forward-looking
statements. Some can be identified by the use of words (and their
derivations) such as "need," "possibility," "potential," "intend,"
"offer," "development," "if," "negotiate," "when," "begun,"
"believe," "achieve," "will," "estimate," "expect," "maintain,"
"plan," and "continue," or the negative of these words. Actual
outcomes and results of operations and the timing of selected
events may differ materially from the results predicted, and any
reported results should not be considered as an indication of
future performance. Such statements are necessarily based on
assumptions and estimates and are subject to various risks and
uncertainties, including those relating to the possible invalidity
of the underlying assumptions and estimates and possible changes or
developments in economic, business, industry, market, legal and
regulatory circumstances and conditions and actions taken or
omitted to be taken by third parties, including customers,
suppliers, business partners, potential licensees, competitors and
legislative, judicial and other governmental authorities and
officials. Factors that could cause or contribute to such
differences include, but are not limited to: unexpected outcomes
with respect to intellectual property enforcement actions, claims
of intellectual property infringement and general intellectual
property litigation; our ability to maintain, develop, monetize and
protect our patent portfolio for both MMR's health IT and
biotechnology intellectual property assets in the U.S. and
internationally; the timing of milestone payments in connection
with licensing our intellectual property; our ability to establish
and maintain strategic relationships; changes in our relationships
with our licensees; the risk MMR's products are not adopted or
viewed favorably by the healthcare community and consumer retail
market; business prospects, results of operations or financial
condition; risks related to the current uncertainty and instability
in financial and lending markets, including global economic
uncertainties; the timing and volume of sales and installations;
the length of sales cycles and the installation process; the
market's acceptance of new product and service introductions;
competitive product offerings and promotions; changes in government
laws and regulations including the 2009 HITECH Act and changes in
Meaningful Use and the 2010 Affordable Care Act; future changes in
tax legislation and initiatives in the healthcare industry;
undetected errors in our products; the possibility of interruption
at our data centers; risks related to third party vendors; risks
related to obtaining and integrating third-party licensed
technology; risks related to a security breach by third parties;
risks associated with recruitment and retention of key personnel;
other litigation matters; uncertainties associated with doing
business internationally across borders and territories; and
additional risks discussed in MMR's filings with the Securities and
Exchange Commission. MMR is providing this information as of the
date of this release and, except as required by applicable law,
does not undertake any obligation to update any forward-looking
statements contained in this release as a result of new
information, future events or otherwise.
CONTACT: MMRGlobal: Bobbie Volman bvolman@mmrmail.com (310)
476-7002, Ext. 7015